Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02984449
Other study ID # METc: 2016/464 UMCG: 201600576
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 3, 2017
Est. completion date August 31, 2025

Study information

Verified date April 2019
Source University Medical Center Groningen
Contact MA Mariani, MD, PhD
Phone 0031503613238
Email m.mariani@umcg.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rationale:

Patients undergoing cardiac surgery are at risk of developing perioperative complications and major adverse cardiac events, mainly related to both their preoperative status and type of surgical procedure. Postoperative exercise based cardiac rehabilitation (CR) is an effective therapy to prolong survival and improve quality of life. However, little is known about the effect on post-operative complications, quality of life and return to work of a combined pre- and post-operative CR program encompassing physical therapy, dietary counseling, psychological support and life style management compared to a CR program, which is provided only after cardiac surgery.

Objective:

to determine whether a pre- and postoperative (PRE+POST) CR program improves the short (up to three months) and long term outcomes (up to one year) of the cardiac surgery (i.e. reduction in postoperative surgical complications, readmissions to hospital and major adverse cardiac events in conjunction with improvements in the physical component of health related quality of life), when compared to postoperative CR only (POST).

Study design:

A Prospective Randomized Open controlled trial, Blinded End-point. Patients are randomized between two standard care CR programs. One group will start a the POST CR program after surgery. The other group will be randomized to a combined PRE+POST CR program.

Study population:

Patients (age > 18 years) admitted for elective coronary bypass surgery, valve surgery and/or aortic surgery

Main study parameters/endpoints:

The primary outcome is a composite weighted endpoint of postoperative surgical complications, re-admissions to hospital, major adverse cardiac events and health related quality of life (two domains: physical functioning and physical problem), at three months and one year after surgery. Endpoints are determined by an independent endpoint committee, blinded to the group allocation. Secondary, the study focuses on physical health (cardiorespiratory fitness, muscle strength and functional status), psychological health (feelings of anxiety and depression), work participation, economics, lifestyle risk factors (physical activity and smoking behavior), self-efficacy and illness representations.


Recruitment information / eligibility

Status Recruiting
Enrollment 350
Est. completion date August 31, 2025
Est. primary completion date August 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients admitted to the department of Thoracic Surgery of the UMCG for:

- coronary artery bypass graft surgery

- valve surgery

- aortic surgery

- or a combination of the surgeries mentioned above

Exclusion Criteria:

- Patients accepted for transcatheter aortic valve implantation (TAVI)

- Patients undergoing congenital heart surgery

- Aortic descendens or dissections surgery

- Elite athletes

- Co-morbidities that prevent participation in one or more program elements (e.g. disorders to the nervous or musculoskeletal system that limits exercise capacity, severe COPD (GOLD class 3-4), addiction to alcohol or drugs/ serious psychiatric illness) or when it is undesirable to exercise (e.g. cardiomyopathy/morrow).

- Other treatment planned that possibly will interrupt the program (for example on a waiting list for an organ transplantation, preoperative endocarditis or planned chemotherapy for cancer etc.)

- Unable to read, write and understand Dutch

Study Design


Intervention

Behavioral:
Pre+post-operative Cardiac rehabilitation
CR has the aim to influence favorably the underlying cause of cardiovascular disease, as well as to provide the best possible physical, mental and social conditions (BACPR, 2012).
Postoperative Cardiac rehabilitation
CR has the aim to influence favorably the underlying cause of cardiovascular disease, as well as to provide the best possible physical, mental and social conditions (BACPR, 2012).

Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Illness perception (IPQ-R), Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Other Cardiac self-efficacy scale (CSA) Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Primary a composite weighted score of functional status, postoperative surgical complications, re-admissions to hospital and major adverse cardiac events Each event, complication or worsening in functional status are considered as a score of 1 to 3 points. These points are summed to calculate the total score. Up to one year post-surgery
Secondary Atrial fibrillation up to one year post-surgery
Secondary prolonged stay at the intensive care unit up to one year post-surgery
Secondary re-thoracotomy up to one year post-surgery
Secondary re-admissions to intensive care unit up to one year post-surgery
Secondary re-admissions to hospital up to one year post-surgery
Secondary All-cause mortality up to five year post-surgery
Secondary six minutes walking test Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Secondary muscle strength This will include grip strength and knee extension Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Secondary functional status (KATZ) Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Secondary Quality of life (Rand-36-v2) Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Secondary Depression (PHQ-9) Baseline, one day before surgery, 4-7 days, 3-4 months and one year post-surgery
Secondary Anxiety (GAD) Depression (PHQ-9), anxiety (GAD), Quality of life (Rand-36-v2) Baseline, one day before surgery, 4-7 days, 3-4 months and one year after surgery
Secondary iMTA Productivity Cost Questionnaire (PCQ) Baseline, 3-4, 7-8 and 12 months post-surgery
Secondary iMTA Medical Cost Questionnaire (MCQ) Baseline, 3-4, 7-8 and 12 months post-surgery
Secondary Lifestyle risk factors Physical activity is assessed using the Sensewear GECKO mini-armband (SWA) and the long version (27 questions) of the International Physical Activity Questionnaire (iPAQ) Baseline, 3-4 months and one year post-surgery
See also
  Status Clinical Trial Phase
Completed NCT03186339 - Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Terminated NCT02854319 - REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System N/A
Recruiting NCT05601453 - The ReTAVI Prospective Observational Registry
Withdrawn NCT05481814 - CPX in Paradoxical Low Flow Aortic Stenosis
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT01700439 - Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve N/A
Recruiting NCT04429035 - SLOW-Slower Progress of caLcificatiOn With Vitamin K2 N/A
Completed NCT04103931 - Impact of a Patient Decision Aid for Treatment of Aortic Stenosis N/A
Completed NCT03950440 - Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
Active, not recruiting NCT02661451 - Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) N/A
Completed NCT02758964 - Evaluation of Cerebral Thrombembolism After TAVR
Completed NCT02792452 - Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
Completed NCT02847546 - Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation N/A
Not yet recruiting NCT02536703 - Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population Phase 3
Not yet recruiting NCT02541877 - Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Phase 3
Not yet recruiting NCT02221921 - Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI N/A
Completed NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Active, not recruiting NCT02080299 - Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation Phase 2
Terminated NCT01939678 - Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease